Synergism Between Clindamycin and Colloidal Bismuth Subcitrate Against Helicobacter (Campylobacter) Pylori in Vitro

Overview

Journal Zentralbl Bakteriol

Specialties Infectious Diseases
Microbiology
Parasitology

Date 1990 Nov 1

PMID 2085373

Citations 2

Authors

K Vogt

H Hahn

Affiliations

Soon will be listed here.

Abstract

A combination of clindamycin and colloidal bismuth subcitrate was evaluated for synergistic inhibition of Helicobacter pylori employing the agar dilution method. A total of 47 clinical isolates of Helicobacter pylori were examined. Synergistic interaction was observed in 36%, additive behaviour in 64% of the strains. No antagonism could be detected.

Citing Articles

Synergistic Therapies as a Promising Option for the Treatment of Antibiotic-Resistant .

Krzyzek P, Paluch E, Gosciniak G Antibiotics (Basel). 2020; 9(10).

PMID: 33007899 PMC: 7599531. DOI: 10.3390/antibiotics9100658.

Combined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro.

Vogt K, Rodloff A, Hahn H Infection. 1991; 19(3):138-9.

PMID: 1832417 DOI: 10.1007/BF01643232.